Economic evaluation of healthcare-associated infection prevention and control in long-term care: a systematic review protocol.
Benefit
Cost
Discount
Economic evaluation
Effectiveness
Healthcare-associated infection
Infection prevention and control
Long-term care facilities
Systematic review
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
03 12 2022
03 12 2022
Historique:
received:
22
08
2021
accepted:
08
11
2022
entrez:
3
12
2022
pubmed:
4
12
2022
medline:
7
12
2022
Statut:
epublish
Résumé
Given the high risk of contracting a healthcare-associated infection in long-term care facilities, infection prevention and control are essential for the quality of care and safety of residents and staff. To develop more effective infection prevention and control interventions in long-term care facilities, it is important to assess the cost-effectiveness and cost-benefit of existing interventions. There are only a few reviews on this subject, but these are not recent and most do not perform an economic evaluation. Moreover, none uses a discounting approach which limits inter-study comparison. To address these gaps, we will conduct a systematic review of economic evaluations related to healthcare-associated infection prevention and control in long-term care facilities using a discounting approach. We will query MEDLINE, Embase, Web of Science, Cochrane, CINAHL, EconLit, JSTOR, and Scopus, as well as the gray literature databases CORDIS and ProQuest. We will include quantitative studies that evaluate four clinical best practices associated with infection prevention and control (hand hygiene, hygiene and sanitation, screening, basic, and additional precautions) and use at least one of five economic analyses (cost-effectiveness, cost-benefit, cost-minimization, cost-utility, cost-consequences). Primary outcomes will include net cost savings, incremental cost-effectiveness ratio, incremental cost per quality-adjusted life year, and incremental cost per disability-adjusted life year. Two co-authors will independently screen and select articles, extract data, and assess the quality of selected articles using the Scottish Intercollegiate Guidelines Network criteria, the Economic Evaluation criteria, and the Cochrane criteria for economic evaluation. Extracted data will be synthesized, and values will be adjusted to 2022 Canadian dollars using the discount rates of 3%, 5%, and 8%. Information obtained through this systematic review may help researchers and policy makers make more efficient use of limited healthcare resources to ensure the safety and quality of long-term care. Research registry ID: reviewregistry1210.
Sections du résumé
BACKGROUND
Given the high risk of contracting a healthcare-associated infection in long-term care facilities, infection prevention and control are essential for the quality of care and safety of residents and staff. To develop more effective infection prevention and control interventions in long-term care facilities, it is important to assess the cost-effectiveness and cost-benefit of existing interventions. There are only a few reviews on this subject, but these are not recent and most do not perform an economic evaluation. Moreover, none uses a discounting approach which limits inter-study comparison. To address these gaps, we will conduct a systematic review of economic evaluations related to healthcare-associated infection prevention and control in long-term care facilities using a discounting approach.
METHODS
We will query MEDLINE, Embase, Web of Science, Cochrane, CINAHL, EconLit, JSTOR, and Scopus, as well as the gray literature databases CORDIS and ProQuest. We will include quantitative studies that evaluate four clinical best practices associated with infection prevention and control (hand hygiene, hygiene and sanitation, screening, basic, and additional precautions) and use at least one of five economic analyses (cost-effectiveness, cost-benefit, cost-minimization, cost-utility, cost-consequences). Primary outcomes will include net cost savings, incremental cost-effectiveness ratio, incremental cost per quality-adjusted life year, and incremental cost per disability-adjusted life year. Two co-authors will independently screen and select articles, extract data, and assess the quality of selected articles using the Scottish Intercollegiate Guidelines Network criteria, the Economic Evaluation criteria, and the Cochrane criteria for economic evaluation. Extracted data will be synthesized, and values will be adjusted to 2022 Canadian dollars using the discount rates of 3%, 5%, and 8%.
DISCUSSION
Information obtained through this systematic review may help researchers and policy makers make more efficient use of limited healthcare resources to ensure the safety and quality of long-term care.
SYSTEMATIC REVIEW REGISTRATION
Research registry ID: reviewregistry1210.
Identifiants
pubmed: 36463274
doi: 10.1186/s13643-022-02128-7
pii: 10.1186/s13643-022-02128-7
pmc: PMC9719189
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
261Informations de copyright
© 2022. The Author(s).
Références
Age Ageing. 2010 May;39(3):299-305
pubmed: 20332371
J Am Geriatr Soc. 2013 Apr;61(4):602-14
pubmed: 23581914
Pharmacoeconomics. 2018 Jul;36(7):745-758
pubmed: 29779120
Eur J Health Econ. 2018 Jul;19(6):831-842
pubmed: 28856487
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Ann Ig. 2013 Mar-Apr;25(2):109-18
pubmed: 23471448
MethodsX. 2020 Aug 28;7:101047
pubmed: 32983920
Soc Sci Med. 2011 Mar;72(6):832-9
pubmed: 21345563
Hosp Cost Manag Account. 1996 Feb;7(11):1-6
pubmed: 10154514
BMJ Open. 2020 Jul 14;10(7):e037765
pubmed: 32665392
PLoS Med. 2016 Oct 18;13(10):e1002150
pubmed: 27755545
Z Gesundh Wiss. 2013;21(6):523-533
pubmed: 24293810
MMWR Recomm Rep. 2003 Jun 6;52(RR-10):1-42
pubmed: 12836624
J Hosp Infect. 2020 Sep;106(1):134-154
pubmed: 32652215
Health Serv Res. 2004 Jun;39(3):627-42
pubmed: 15149482
Cochrane Database Syst Rev. 2018 Feb 26;2:CD010768
pubmed: 29481693
J Adv Nurs. 2017 Jul;73(7):1696-1711
pubmed: 28103397
Epidemiol Infect. 2009 Feb;137(2):145-55
pubmed: 18474129
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Clin Infect Dis. 2010 Oct 15;51(8):931-6
pubmed: 20822459
BMC Nephrol. 2017 Dec 28;18(1):375
pubmed: 29282006
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Hosp Cost Manag Account. 1993 Aug;5(5):1-6
pubmed: 10127685
Am J Infect Control. 2016 Feb;44(2):160-6
pubmed: 26521700
Int J Technol Assess Health Care. 2013 Apr;29(2):117-22
pubmed: 23587340
PLoS One. 2020 Mar 10;15(3):e0229911
pubmed: 32155208
J Hosp Infect. 2019 Aug;102(4):377-393
pubmed: 30794854
Nurs Econ. 2016 Jan-Feb;34(1):16-24
pubmed: 27055307
Crit Care Nurs Clin North Am. 2017 Mar;29(1):51-65
pubmed: 28160957